Following a call for tender for its document control services, GSK Biologicals recently announced its decision to entrust Exquando with a three-year collaboration starting on 1 April 2011.
The agreement is for the delivery of document control and document management services for around 40 construction projects representing an investment of several hundred million Euros per year. Exquando will operate with a team of document control professionals and with the help of document operators based in Vietnam.
GSK Biologicals is part of the GlaxoSmithKline Group, the world’s second largest leading research-based pharmaceutical and healthcare group. GSK Biologicals, with its headquarters in Wavre, Belgium, is one of the world’s leading vaccine producers and employs around 6,200 people worldwide.
For its major Belgian and international engineering and construction projects, GSK Biologicals was looking to develop a long-term partnership with a reliable and professional service provider to which it could delegate its document control activities.
The strengths of Exquando offer relies in its long expertise and track record of innovation in Entreprise Content Management; its profound knowledge and understanding of GSK Biologicals, its projects and its people; its partnerships with well-established organizations; and last but not least its team of content professionals who have an in-depth understanding of the document control discipline.
Marc Ansoult and Dara Duong, Exquando co-founders and Managing Directors, comment: “This collaboration is a major milestone for Exquando as it consolidates our ongoing working relationship with GSK Biologicals and enables us to continue bringing our know-how, enthusiasm and professionalism for the benefit of our client and its partners.”
We do not collect personal data via this website. Every data provided to us through the contact forms of this website is used to facilitate routine contact and operational work.
Data is held securely and is subject to access controls.
For any question related to our Data Protection Policies and process, please contact us at